Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11435366
Noninvasive method to quantify kidney function and functional decline
granted -
US 11434485
Synthetic transfer RNA with extended anticodon loop
granted -
US 11434301
Anti-CD46 antibodies and methods of use
granted -
US 11434300
Methods and antibody compositions for tumor treatment
granted -
US 11434304
Anti-CD38 antibodies
granted -
US 11434487
Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
granted -
US 11434297
CD123-binding polypeptides and uses thereof
granted -
US 11435349
CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs
granted -
US 11434278
Protein-polymer-drug conjugates
granted -
US 11434505
Universal donor cells
granted -
US 11434268
Vascular endothelial growth factor antagonists
granted -
US 11434267
Peptides having reduced toxicity that stimulate cholesterol efflux
granted -
US 11434233
Heterocyclic inhibitors of ATR kinase
granted -
US 11433137
Compounds for treating cancer
granted -
US 11433126
Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
granted -
US 11433102
Compositions and methods for treating Parkinson's disease (PD) and related disorders
granted -
US 11433118
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11433103
Universal donor cells
granted -
US 11433097
Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
granted -
US 11433078
Pharmaceutical compositions comprising meloxicam
granted -
US 11433088
Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide
granted -
US 11433079
Pharmaceutical compositions comprising meloxicam
granted -
US 11433057
Method for improving or enhancing cognition
granted -
US 11434204
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.